Insufficient scRNA-seq data for expression of CCNB3 at single-cell level.
Insufficient scRNA-seq data for expression of CCNB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 63.62 | 2593 / 2642 | 46% | 0.85 | 321 / 705 |
breast | 98% | 38.64 | 451 / 459 | 35% | 0.84 | 393 / 1118 |
skin | 99% | 46.60 | 1792 / 1809 | 20% | 0.38 | 93 / 472 |
lung | 99% | 68.63 | 572 / 578 | 10% | 0.30 | 117 / 1155 |
adrenal gland | 98% | 58.12 | 252 / 258 | 8% | 0.16 | 18 / 230 |
pancreas | 96% | 40.13 | 315 / 328 | 7% | 0.08 | 12 / 178 |
liver | 95% | 32.31 | 214 / 226 | 8% | 0.11 | 31 / 406 |
thymus | 98% | 44.95 | 642 / 653 | 4% | 0.07 | 23 / 605 |
stomach | 89% | 49.21 | 321 / 359 | 11% | 0.29 | 32 / 286 |
kidney | 96% | 35.48 | 85 / 89 | 5% | 0.07 | 43 / 901 |
spleen | 99% | 47.66 | 238 / 241 | 0% | 0 | 0 / 0 |
adipose | 94% | 35.69 | 1135 / 1204 | 0% | 0 | 0 / 0 |
muscle | 94% | 59.06 | 751 / 803 | 0% | 0 | 0 / 0 |
prostate | 84% | 20.76 | 207 / 245 | 9% | 0.12 | 43 / 502 |
intestine | 84% | 21.53 | 813 / 966 | 6% | 0.14 | 33 / 527 |
esophagus | 74% | 15.23 | 1063 / 1445 | 16% | 0.48 | 29 / 183 |
bladder | 76% | 20.52 | 16 / 21 | 9% | 0.20 | 47 / 504 |
ovary | 67% | 17.62 | 120 / 180 | 19% | 0.46 | 80 / 430 |
uterus | 58% | 11.68 | 99 / 170 | 13% | 0.32 | 59 / 459 |
heart | 56% | 10.42 | 484 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 54% | 10.13 | 724 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 11.69 | 455 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 19% | 0.23 | 15 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0051301 | Biological process | cell division |
GO_0044772 | Biological process | mitotic cell cycle phase transition |
GO_0016607 | Cellular component | nuclear speck |
GO_0005813 | Cellular component | centrosome |
GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CCNB3 |
Protein name | G2/mitotic-specific cyclin-B3 Cyclin B3 |
Synonyms | CYCB3 |
Description | FUNCTION: Cyclins are positive regulatory subunits of the cyclin-dependent kinases (CDKs), and thereby play an essential role in the control of the cell cycle, notably via their destruction during cell division. Its tissue specificity suggest that it may be required during early meiotic prophase I. . |
Accessions | ENST00000276014.11 [Q8WWL7-1] ENST00000376038.5 [Q8WWL7-2] ENST00000376042.6 [Q8WWL7-1] ENST00000348603.2 [Q8WWL7-2] Q8WTR6 Q8WWL7 ENST00000476167.5 [Q8WWL7-3] |